Skip to Content

WATSON 3359 WATSON 3359 (Tacrolimus 5 mg)

Pill with imprint WATSON 3359 WATSON 3359 is Pink, Capsule-shape and has been identified as Tacrolimus 5 mg. It is supplied by Watson Laboratories, Inc..

Tacrolimus is used in the treatment of organ transplant, rejection prophylaxis; organ transplant, rejection reversal and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 3359 WATSON 3359

Tacrolimus 5 mg WATSON 3359 WATSON 3359

Tacrolimus

Imprint
WATSON 3359 WATSON 3359
Strength
5 mg
Color
Pink
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Calcineurin inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-3359
Inactive Ingredients
lactose anhydrous, croscarmellose sodium, hypromelloses, magnesium stearate, gelatin, titanium dioxide, FD&C Blue No. 1, FD&C Red No. 3, FD&C Red No. 40

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.